|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-induced glucose-stimulated insulin secretion inhibition in INS-1 cells is ascribed to a reduction of the glucose-stimulated Ca2+ influx
Institute for Medical Science, Ajou University School of Medicine, 442-749 Suwon, Republic of Korea1 Division of Science Education, Chungbuk National University, 361-763 Chongju, Republic of Korea2 Korea National University of Education, 363-791 Chungbuk, Republic of Korea
(Correspondence should be addressed to Y Kang; Email: kangy{at}ajou.ac.kr)
* (H-E Kim and S-E Choi contributed equally to this work)
The present study was undertaken to determine how tumour necrosis factor-
(TNF-
) elicits the inhibition of glucose-stimulated insulin secretion (GSIS) in rat insulinoma cells (INS)-1 β-cells. TNF-
pretreatment did not change the expression levels of insulin, PDX-1, glucose transporter 2, glucokinase, KATP channels, Ca2+ channels, and exocytotic molecules and, furthermore, did not reduce the glucose-stimulated ATP level. On the other hand, TNF-
reduced the glucose-stimulated influx of Ca2+. The TNF-
treatment was thought to activate c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (MAPK), and NF-
B inflammatory signals, since TNF-
increased phospho-JNK and phospho-p38 and reduced I
B levels. Inhibitors of these signaling pathways prevented the TNF-
-induced reduction of the Ca2+ influx and GSIS. Overexpression of MEKK3, a possible mediator from the TNF-
receptor to the JNK/p38 and NK-
B signaling cascade, increased the levels of phospho-JNK, phospho-p38, and NF-
B, and reduced the glucose-stimulated Ca2+ influx and GSIS. The reduction of the Ca2+ influx and GSIS in MEKK3-overexpressing INS-1 cells was also prevented by inhibitors of JNK, p38, and NF-
B. These data demonstrate that TNF-
inhibits GSIS by reducing the glucose-stimulated Ca2+ influx, possibly through the activation of JNK and p38 MAPK and NF-
B inflammatory signals. Thus, our findings suggest that the activation of stress and inflammatory signals can contribute to the inhibition of GSIS in the development of diabetes.
This article has been cited by other articles:
![]() |
K. Bouzakri, P. Ribaux, and P. A. Halban Silencing Mitogen-activated Protein 4 Kinase 4 (MAP4K4) Protects Beta Cells from Tumor Necrosis Factor-{alpha}-induced Decrease of IRS-2 and Inhibition of Glucose-stimulated Insulin Secretion J. Biol. Chem., October 9, 2009; 284(41): 27892 - 27898. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |